@article{db78425a8a154a2c97fa0db6abad3759,
title = "Anaphylaxis in the young adult population",
abstract = "It is critical that clinicians treating young adults understand the presentation and management of anaphylaxis. The most common trigger for anaphylaxis in this population is food. The prevalence of food allergy is growing, with 8% of US children and adolescents affected. All patients at risk for anaphylaxis should be prescribed epinephrine autoinjectors, as epinephrine is the only life-saving medication for a severe anaphylactic reaction. The presentation of anaphylaxis can involve multiple organ systems (eg, mucocutaneous, respiratory, cardiovascular, gastrointestinal) and, as such, patient education is needed to assist in prompt recognition. Appropriate training of patients and caregivers about how to identify anaphylaxis and what to do in an emergency is critical. Training of school and college staff also is essential, as 1 in 4 first-time reactions occurs outside the home. Additional counseling for adolescents at risk for anaphylactic reactions should address increased risk-taking behavior, decreased adult supervision, dating, and the transition of disease management from an adult to the patient.",
keywords = "Adolescents, Allergy, Anaphylaxis, Children, Epinephrine, Risk-taking behavior, School safety, Young adults",
author = "Gupta, {Ruchi S.}",
note = "Funding Information: Funding: This work was supported by Mylan Specialty L.P. Funding Information: Conflict of Interest: Ruchi S. Gupta, MD, MPH has served as an advisor and speaker for Mylan Specialty L.P.; she received an honorarium from Mylan for attending the Partnership for Anaphylaxis Round Table. No payment was received for writing of this manuscript. Dr Gupta has received research support from the National Institutes of Health, Mylan, and FARE. Funding Information: This article is based on a presentation authored and delivered by Ruchi S. Gupta, MD, MPH, at the multidisciplinary Partnership for Anaphylaxis Round Table meeting, held in November 2012, in Dallas, Texas. The round table meeting was supported by Mylan Specialty L.P. Medical writing and editorial assistance for the preparation of this manuscript were provided by Jeff Kuper, PharmD, of PharmaWrite, LLC, and were funded by Mylan Specialty L.P. This manuscript is an original work and was prepared according to the International Society for Medical Publication Professionals' Good Publication Practice for Communicating Company-Sponsored Medical Research: the GPP2 Guidelines. The author thanks Claudia H. Lau, Ashley Dyer, MPH, and Elizabeth Sita for their review of and comments on this manuscript. The author also thanks Dr Kuper for his assistance. Copyright: Copyright 2014 Elsevier B.V., All rights reserved.",
year = "2014",
month = jan,
doi = "10.1016/j.amjmed.2013.09.010",
language = "English (US)",
volume = "127",
pages = "S17--S24",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "1 SUPPL.",
}